Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

22 July 2022: Database Analysis

Role of Serum Creatinine Levels in Prognostic Risk Stratification of Prostate Cancer Patients

Xingbo Gu 1ACDEFG* , Jiaojiao Wu 1BCDEF , Xuefeidan Liu 2AD , Yun Hong 1BCDF , Yaoxi Wu 3AD , Ye Tian 1AD*

DOI: 10.12659/MSM.937100

Med Sci Monit 2022; 28:e937100

Table 2 Odds ratio and 95% confidence interval of 1134 patients with prostate cancer according to the quintiles of serum creatinine.

Serum creatinine (umol/L)
Q1: <70.1Q2: 70.1–76.8Q3: 76.8–83.4Q4: 83.4–92.1Q5: ≥92.1
ModelOR (95% CI)OR (95% CI)OR (95% CI)OR (95% CI)OR (95% CI)
Number of patients222225227229228
Model13.62 (1.73, 7.56)Ref3.02 (1.43, 6.39)3.24 (1.54, 6.80)3.77 (1.81, 7.83)
Model23.66 (1.75, 7.67)Ref3.00 (1.42, 6.34)3.27 (1.55, 6.87)3.76 (1.80, 7.87)
Model34.87 (1.91, 12.38)Ref4.62 (1.81, 11.78)4.25 (1.69, 10.71)5.46 (2.16, 13.80)
crude. adjusted for age and BMI. adjusted for age, BMI, serum albumin, alkaline phosphatase, creatine kinase isoenzyme, serum calcium, serum phosphorus, lactic dehydrogenase, low-density lipoprotein cholesterol, and apolipoprotein A1.

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750